期刊文献+

胃癌肝转移综合治疗 被引量:2

Comprehensive treatment of gastric cancer with liver metastasis
原文传递
导出
摘要 肝转移是胃癌发展的终末阶段,是导致死亡的主要原因,并且是晚期胃癌的治疗难点之一。目前,多种方法被用来控制胃癌肝转移,包括手术切除、系统治疗、消融治疗、介入治疗和靶向治疗,但是具体方案尚无定论。多学科团队(MDT)综合治疗模式已经使更多的病人获得了生存期的延长及生活质量的提高,因此,掌握各种治疗方法的适应证尤为重要。 Liver metastasis is the main cause of death of patients with gastric cancer at the end stage. It is still a challenge to treat gastric cancer with liver metastases (GCLM). Multiple therapeutic managements have been employed to control the progression of GCLM, including surgery, systemic therapy, ablation therapy, intervention therapy and targeted therapy, but still controversial As the multidisciplinary team (MDT) treatment has prolonged the survival time and improved the survival quality, mastering the indications and usage of all kinds of therapeutic managements has become crucial extremely.
出处 《中国实用外科杂志》 CSCD 北大核心 2015年第10期1078-1082,共5页 Chinese Journal of Practical Surgery
基金 国家自然科学基金项目(No.81372295 No.81402374)
关键词 胃癌 肝转移 综合治疗 gastric cancer liver metastasis comprehensive treatment
  • 相关文献

参考文献24

  • 1Koga R, Yamamoto J, Ohyama S, et al. Liver resection for meta- static gastric cancer: experience with 42 patients including eight long-term survivors [J]. Jpn J Clin Oneol, 2007, 37(11):836 - 842.
  • 2Sakamoto Y, Sano T, Shimada K, et al. Favorable indications for hepateetomy in patients with liver metastasis from gastric cancer [J]. J Surg Oncol, 2007, 95(7):534 - 539.
  • 3Cheon SH, Rha SY, Jeung HC, et al. Survival benefit of com- bined curative resection of the stomach ( D2 resection) and liver in gastric cancer patients with liver metastases [J]. Ann Oneol, 2008, 19(15):1146-1153.
  • 4Tiberio GA, Coniglio A, Marehet A, et al. Metaehronous hepatic metastases from gastric carcinoma: a multieentrie survey[J]. Eur J Surg Oneol, 2009, 35(5): 486-491.
  • 5Hwang SE, Yang DH, Kim CY. Prognostic factors for survival in patients with hepatic recurrence after curative resection of gas- trie cancer[J]. World J Surg, 2009, 33(7):1468-1472.
  • 6Thelen A, Jonas S, Benckert C, et al. Liver resection for meta- static gastric cancer [J]. Eur J Surg Oncol, 2008, 34(12):1328-1334.
  • 7Okano K, Maeba T, Ishimura K, et al. Hepatic resection for met- astatic tumors from gastric cancer[J]. Ann Surg, 2002, 235(1): 86-91.
  • 8陈峻青.第4版日本《胃癌治疗指南》中7个“临床问题”解析[J].中国实用外科杂志,2015,35(4):357-359. 被引量:9
  • 9Kerkar SP, Kemp CD, Duffy A, et al. The GYMSSA trial: a pro- spective randomized trial comparing gastrectomy, metastasecto- my plus systemic therapy versus systemic therapy alone[J]. Tri- als, 2009, 10(1):121.
  • 10Mezhir JJ, Tang LH, Colt DG, et al. Neoadjuvant therapy of lo- cally advanced gastric cancer [J]. J Surg Oncol, 2010,101(4): 305-314.

二级参考文献28

  • 1陈峻青,王梅先,齐春莲,王舒宝,单吉贤,张文范,张荫昌.胃癌淋巴结转移及其分型的病理生物学意义[J].实用外科杂志,1989,9(9):478-480. 被引量:24
  • 2Zi-Yu Li,Lei Tang,Lian-Hai Zhang,Zhao-De Bu,Ai-Wen Wu,Xiao-Jiang Wu,Xiang-Long Zong,Qi Wu,Fei Shan,Shuang-Xi Li,Hui Ren,Xiao-Peng Zhang,Jia-Fu Ji.Weekly docetaxel and cisplatin plus fluorouracil as a preoperative treatment for gastric cancer patients with synchronous multiple hepatic metastases: a pilot study[J]. Medical Oncology . 2010 (4)
  • 3Yasushi Sato,Tetsuji Takayama,Tamotsu Sagawa,Yasuo Takahashi,Hiroyuki Ohnuma,Syunichi Okubo,Naoaki Shintani,Shingo Tanaka,Masaya Kida,Yasuhiro Sato,Hidetoshi Ohta,Koji Miyanishi,Tsutomu Sato,Rishu Takimoto,Masayoshi Kobune,Koji Yamaguchi,Koichi Hirata,Yoshiro Niitsu,Junji Kato.Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer[J]. Cancer Chemotherapy and Pharmacology . 2010 (4)
  • 4Hironori Tsujimoto,Takashi Ichikura,Satoshi Ono,Hidekazu Sugasawa,Shuichi Hiraki,Naoko Sakamoto,Yoshihisa Yaguchi,Kazuo Hatsuse,Junji Yamamoto,Kazuo Hase.Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer[J]. Hepatology International . 2010 (1)
  • 5Chen Li,Min Yan,Jun Chen,Min Xiang,Zheng Gang Zhu,Hao Ran Yin,Yan Zheng Lin.Survival Benefit of Non-curative Gastrectomy for Gastric Cancer Patients with Synchronous Distant Metastasis[J]. Journal of Gastrointestinal Surgery . 2010 (2)
  • 6Kentaro Ueda,Makoto Iwahashi,Mikihito Nakamori,Masaki Nakamura,Teiji Naka,Koichiro Ishida,Toshiyasu Ojima,Hiroki Yamaue.Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer[J]. Langenbeck’s Archives of Surgery . 2009 (4)
  • 7Si-Eun Hwang,Doo-Hyun Yang,Chan-Young Kim.Prognostic Factors for Survival in Patients with Hepatic Recurrence After Curative Resection of Gastric Cancer[J]. World Journal of Surgery . 2009 (7)
  • 8Takashi Nomura,Yukinori Kamio,Naoki Takasu,Toshiyuki Moriya,Akiko Takeshita,Masaomi Mizutani,Osamu Hachiya,Ichiro Hirai,Wataru Kimura.Intrahepatic micrometastases around liver metastases from gastric cancer[J]. Journal of Hepato - Biliary - Pancreatic Surgery . 2009 (4)
  • 9Ahmed Ba-Ssalamah,Martin Uffmann,Sanjai Saini,Nina Bastati,Christian Herold,Wolfgang Schima.Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions[J]. European Radiology . 2009 (2)
  • 10Kerkar SP,Kemp CD,Duffy A,et al.The GYMSSA trial:a pro-spective randomized trial comparing gastrectomy,metastasecto-my plus systemic therapy versus systemic therapy alone. Tri-als . 2009

共引文献17

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部